{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:58:43Z","timestamp":1784638723479,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nmd.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T22:41:42Z","timestamp":1557441702000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Inflammation-induced fibrosis in skeletal muscle of female carriers of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"29","author":[{"given":"Corinna","family":"Preu\u00dfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpad","family":"von Moers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Pehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Hilmar","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2019.05.003_bib0001","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","volume":"21","author":"Dumont","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2019.05.003_bib0002","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/srep00399","article-title":"Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle","volume":"2","author":"Eghtesad","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2019.05.003_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mt.2010.219","article-title":"The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy","volume":"19","author":"Lu","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2019.05.003_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2011.127","article-title":"Prednisolone treatment does not interfere with 2\u2019-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy","volume":"23","author":"Verhaart","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nmd.2019.05.003_bib0006","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(98)10028-4","article-title":"Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study","volume":"353","author":"Hoogerwaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2019.05.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-0004.1974.tb01694.x","article-title":"The manifesting carrier in Duchenne muscular dystrophy","volume":"5","author":"Moser","year":"1974","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2019.05.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-0004.1989.tb03363.x","article-title":"A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales","volume":"36","author":"Norman","year":"1989","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2019.05.003_bib0009","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nmd.2010.05.010","article-title":"Clinical and genetic characterization of manifesting carriers of DMD mutations","volume":"20","author":"Soltanzadeh","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2019.05.003_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2350-13-73","article-title":"Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype","volume":"13","author":"Brioschi","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.nmd.2019.05.003_bib0011","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"Preu\u00dfe","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0012","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Benveniste O, Goebel H, Stenzel W. Integrated classification of inflammatory myopathies (2017):62\u201381.","DOI":"10.1111\/nan.12380"},{"key":"10.1016\/j.nmd.2019.05.003_bib0013","unstructured":"Allenbach Y, Leroux G, Su\u00e1rez-calvet X, Preusse C, Gallardo E, Hervier B, et al. Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies common interferon signature but distinct NOS2 expression 2016;186."},{"key":"10.1016\/j.nmd.2019.05.003_bib0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"Dalakas","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nmd.2019.05.003_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC international workshop: pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2019.05.003_bib0016","first-page":"141","article-title":"Immune effector mechanisms in inflammatory myopathies","volume":"68","author":"Engel","year":"1990","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1016\/j.nmd.2019.05.003_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC international workshop::: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2019.05.003_bib0018","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP and anti-HMGCR myopathies role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.05.003_bib0019","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2019.05.003_bib0021","doi-asserted-by":"crossref","first-page":"R1173","DOI":"10.1152\/ajpregu.00735.2009","article-title":"Regulatory interactions between muscle and the immune system during muscle regeneration","volume":"298","author":"Tidball","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0022","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0023","first-page":"14","volume":"41","author":"Murray","year":"2015","journal-title":"Experimental Guidelines"},{"key":"10.1016\/j.nmd.2019.05.003_bib0024","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00109-015-1286-y","article-title":"Transcriptional programming of human macrophages: on the way to systems immunology","volume":"93","author":"Schultze","year":"2015","journal-title":"J Mol Med"},{"key":"10.1016\/j.nmd.2019.05.003_bib0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0026","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0710409","article-title":"Obstacles and opportunities for understanding macrophage polarization","volume":"89","author":"Murray","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0028","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0029","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.nmd.2019.05.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010763","article-title":"Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy","volume":"5","author":"Wehling-Henricks","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2019.05.003_bib0031","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/hmg\/ddq523","article-title":"Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype","volume":"20","author":"Villalta","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"258","key":"10.1016\/j.nmd.2019.05.003_bib0032","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/scitranslmed.3009925","article-title":"Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy","volume":"6","author":"Villalta","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nmd.2019.05.003_bib0033","first-page":"3831","article-title":"IFN\u03b3 promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation","volume":"71","author":"Villalta","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00914","article-title":"Increased number of circulating CD8\/CD26 T cells in the blood of duchenne muscular dystrophy patients is associated with augmented binding of adenosine deaminase and higher muscular strength scores","volume":"8","author":"Soslow","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1212\/WNL.41.5.667","article-title":"Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD study group","volume":"41","author":"Kissel","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.05.003_bib0036","first-page":"3831","article-title":"Transforming Growth Factor (TGF)-\u00df signaling in cardiac remodeling","volume":"71","author":"Dobaczewski","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0037","doi-asserted-by":"crossref","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2\u2013Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2019.05.003_bib0038","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1159\/000487871","article-title":"Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF-\u03b21\/Smad3 and NF-\u03baB signaling pathways in a rat model of myocardial infarction","volume":"45","author":"Han","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.nmd.2019.05.003_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.abb.2018.01.006","article-title":"Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK\/TGF-\u03b2\/Smads signaling pathway","author":"Xiao","year":"2018","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nmd.2019.05.003_bib0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nmd.2019.05.003_bib0041","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejrad.2010.07.005","article-title":"Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study","volume":"80","author":"Walcher","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0042","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5582\/irdr.2018.01003","article-title":"Muscular and cardiac manifestations in a Duchenne-carrier harboring a dystrophin deletion of exons 12-29","volume":"7","author":"Finsterer","year":"2018","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.nmd.2019.05.003_bib0043","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2015.11.004","article-title":"Genetic and early clinical manifestations of females heterozygous for Duchenne\/Becker muscular dystrophy","volume":"55","author":"Papa","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2019.05.003_bib0044","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3346\/jkms.2011.26.4.587","article-title":"Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis","volume":"26","author":"Yoon","year":"2011","journal-title":"J Kor Med Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661831383X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661831383X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:07:48Z","timestamp":1760774868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661831383X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S096089661831383X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.05.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation-induced fibrosis in skeletal muscle of female carriers of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}